DarioHealth Corp.
DRIO
$6.28
$0.223.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -24.41% | -17.31% | 7.29% | 41.79% | 47.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.41% | -17.31% | 7.29% | 41.79% | 47.21% |
| Cost of Revenue | -3.98% | -8.24% | -12.41% | -3.80% | -8.05% |
| Gross Profit | -33.42% | -21.65% | 19.93% | 79.04% | 100.26% |
| SG&A Expenses | -17.22% | -22.94% | -20.77% | -18.03% | -7.53% |
| Depreciation & Amortization | -79.49% | -66.79% | -42.68% | -14.48% | 6.09% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.23% | -29.79% | -23.37% | -17.02% | -4.90% |
| Operating Income | 28.85% | 35.71% | 35.12% | 34.71% | 21.04% |
| Income Before Tax | 9.05% | 6.70% | 14.60% | 16.53% | 19.88% |
| Income Tax Expenses | -14.63% | 105.67% | 109.11% | 108.50% | 108.50% |
| Earnings from Continuing Operations | 9.07% | 2.42% | 10.73% | 13.04% | 16.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.07% | 2.42% | 10.73% | 13.04% | 16.69% |
| EBIT | 28.85% | 35.71% | 35.12% | 34.71% | 21.04% |
| EBITDA | 21.99% | 32.41% | 35.96% | 39.17% | 26.94% |
| EPS Basic | 18.13% | 12.97% | 37.39% | 42.19% | 64.61% |
| Normalized Basic EPS | 42.53% | 33.67% | 47.63% | 46.86% | 49.56% |
| EPS Diluted | 18.13% | 12.97% | 37.39% | 42.19% | 64.62% |
| Normalized Diluted EPS | 42.53% | 33.67% | 47.63% | 46.86% | 49.56% |
| Average Basic Shares Outstanding | 94.80% | 64.27% | 66.19% | 63.87% | 71.58% |
| Average Diluted Shares Outstanding | 94.80% | 64.27% | 66.19% | 63.87% | 71.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |